Primary signet ring cell carcinoma of the colon and rectum

Bull Cancer. 2015 Oct;102(10):880-8. doi: 10.1016/j.bulcan.2015.07.005. Epub 2015 Sep 26.

Abstract

Colorectal primary signet ring cell carcinoma (SRCC) is a rare entity accounting for nearly 1% of all colorectal carcinomas. It is an independent prognostic factor associated with less favorable outcome. This aggressiveness is mainly due to the intrinsic biology of these tumors. Here is an overview of the literature related to clinicopathological features, molecular biology, and management of SRCC of the colon and the rectum.

Keywords: Colorectal cancer; Molecular biology; Pathology; Signet ring cell; Treatment.

Publication types

  • Review

MeSH terms

  • Carcinoma, Signet Ring Cell* / epidemiology
  • Carcinoma, Signet Ring Cell* / genetics
  • Carcinoma, Signet Ring Cell* / pathology
  • Carcinoma, Signet Ring Cell* / therapy
  • Colonic Neoplasms* / epidemiology
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / therapy
  • Genes, ras
  • Humans
  • Incidence
  • Loss of Heterozygosity
  • Microsatellite Instability
  • Mucin 5AC / metabolism
  • Mucin-2 / metabolism
  • Mutation
  • Neoplasm Proteins / metabolism
  • Prognosis
  • Rare Diseases* / epidemiology
  • Rare Diseases* / genetics
  • Rare Diseases* / pathology
  • Rare Diseases* / therapy
  • Rectal Neoplasms* / epidemiology
  • Rectal Neoplasms* / genetics
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / therapy
  • raf Kinases / genetics

Substances

  • MUC2 protein, human
  • MUC5AC protein, human
  • Mucin 5AC
  • Mucin-2
  • Neoplasm Proteins
  • raf Kinases